Moderna and Merck's Phase 3 melanoma vaccine trial showed positive results, but full data and FDA approval are still pending ...

Artificial intelligence (AI) tools can help physicians predict treatment and survival outcomes in patients with advanced ...

New funding is coming for projects throughout the state, including two important medical projects at Binghamton University.

Moderna built an artificial intelligence that reads a patient’s tumor and decides what that patient’s medicine should be.

Ataraxis AI, a company building clinical AI tools to personalize cancer care, today announced scientific breakthroughs and validation results of Ataraxis’s AI models.

Eric Lefkofsky, Tempus AI founder and CEO, joins 'The Exchange' to discuss AI's role in healthcare, advancing cancer research ...

AI's Growing Role in Medical Care Raises Concerns ...

The survivorship cliff is where cancer treatment ends and structured care stops. Patients and clinicians named the same gap ...

Big manufacturers planning to produce more of the forever chemicals to meet demand from datacentres ...

Agreement to collaborate, starting with cyber-security and medicine, would be his biggest achievement, writes Gary Marcus ...

A new national survey finds just 20% of U.S. men know that dairy consumption has been linked to a higher risk of prostate ...

"This is a very promising tool. So I feel like it can be employed very well. That's why I am not in the bracket of people who are overly worried about it," he says.